Industry Trends

May 2020

See what has been happening in Asia’s pharma and personal care industries over the last weeks. What are experts and industry magazines talking about?

What has been happening?

Thigh circumference tied to hypertension risk, first non-hormonal contraceptive gel, seniors with COVID-19 taking hypertension medication at lower risk of hospitalization, and more.  Find out what journals and industry experts have been discussing in the last four weeks.

Latest Industry Articles

Thigh Circumference Tied to Hypertension Risk
Drugs.com

Large thigh circumference is associated with a lower risk for hypertension in overweight and obese individuals, according to a study published in the April issue of Endocrine Connections.
FDA Approves First Non-Hormonal Contraceptive Gel
Forbes

The FDA approved the first non-hormonal prescription birth control gel. It works by maintaining your vaginal pH within the normal range which is acidic and inhospitable to sperm.
Study Finds Seniors with COVID-19 Taking Hypertension Medication at Lower Risk of Hospitalization, Clinical Trial to Follow Immediately
Business Wire

A study completed by UnitedHealth Group (NYSE: UNH) with the Yale School of Medicine found that older COVID-19 patients with hypertension taking angiotensin-converting enzyme (ACE) inhibitors had a lower risk of COVID-19 hospitalization. A pragmatic clinical trial will be a critical next step.
Higher Intake of Whole-Fat Dairy May Cut Metabolic Syndrome Risk
Drugs.com

Higher intake of whole-fat dairy products is associated with a lower prevalence of metabolic syndrome (MetS) as well as hypertension and diabetes, according to a study published online May 18 in BMJ Open Diabetes Research & Care.
Intensive Blood Pressure Control Tied to Lower Atrial Fibrillation Risk
Drugs.com

Intensive blood pressure (BP) control can lower the risk for atrial fibrillation (AF) in patients with hypertension at high risk for cardiovascular disease, according to a study published online May 4 in Hypertension
Colonoscopy Screening Intervals Could Be Extended For Some Patients, Researchers Suggest
Forbes

The traditional 10-year colonoscopy interval may be changing. The standard advice for average-risk adults (ages 50-66) who have a negative colonoscopy is to have another one in 10 years.
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus
Business Wire Health

Moderna and Lonza announce worldwide strategic collaboration to manufacture Moderna’s vaccine (mRNA-1273) against novel coronavirus.
Musculoskeletal Malformations Up With Fluconazole in Pregnancy
Drugs.com

Use of oral fluconazole for treatment of vulvovaginal candidiasis in the first trimester of pregnancy is associated with musculoskeletal malformations, but not with oral clefts or conotruncal malformations, according to a study published online May 20
Vitamins, fruit and veg extracts ‘most appealing’ beauty ingredients, finds GlobalData
CosmeticsDesign

Consumers worldwide find vitamins, fruit and vegetable extracts the most appealing beauty ingredients, but there are others they remain wary of or confused by, according to GlobalData.
Melanoma Risk From Biologic Therapy Remains Uncertain
Drugs.com

Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a review published online May 20
Anti-pollution beauty: Unilever files patent on protective resin-based film formers
CosmeticsDesign

Personal care major Unilever has filed a patent on the use of resin-based film formers to prevent pollution-triggered skin damage.

Related Articles & Trends

Pharma & Personal Care Trends – November 2024

Pharma & Personal Care Trends – November 2024

Beauty 4.0: The state of the menopausal beauty market, New skin care line to address interest in Traditional Chinese Medicine and well-being surges, Benefits of transitioning to E-Cigarettes, and more. See what industry experts have been discussing in the last four weeks.

Pharma & Personal Care Trends – October 2024

Pharma & Personal Care Trends – October 2024

Sustainable cosmetic packaging innovations at Luxe Pack 2024, One or two-dose HPV vaccination, 3 ways to maintain glowy skin, and more. See what industry experts have been discussing in the last four weeks.

Pharma & Personal Care Trends – September 2024

Pharma & Personal Care Trends – September 2024

Rutin emerges as a sustainable alternative in sunscreen formulations, Infusing sustainability and transparency into skin care, Formulating menopausal skin care, and more. See what industry experts have been discussing in the last four weeks.

Industry News . Once a month . No spam